Emgality (Galcanezumab): Complete Guide to Uses, Dosing, and Finding It in Stock

What Is Emgality?

Emgality is the brand name for galcanezumab, a prescription biologic medication belonging to a class called CGRP monoclonal antibodies — one of the most significant advances in migraine treatment in decades. Unlike older migraine drugs that were repurposed from other conditions, Emgality was specifically designed and developed for migraine prevention. It works by targeting a protein in the nervous system that plays a direct role in triggering migraine attacks, rather than just dulling the pain after it starts.

The FDA approved Emgality in September 2018 for two distinct indications: preventive treatment of migraine in adults, and treatment of episodic cluster headache in adults. Emgality is manufactured by Eli Lilly and Company and is currently available only as a brand-name product — there is no FDA-approved generic version of galcanezumab at this time. Because it is a biologic (derived from living cells rather than synthesized chemically), any future generic equivalent would technically be called a biosimilar, and none have been approved as of this writing. It is not a controlled substance, which means prescribing and dispensing carry fewer regulatory hurdles than Schedule II or III drugs.

Emgality is primarily prescribed to adults who experience frequent migraines — typically four or more per month — and who have not found adequate relief with standard preventive options like beta-blockers, antidepressants, or anticonvulsants. It is also used by adults experiencing episodic cluster headaches, a notoriously painful and difficult-to-treat condition sometimes called "suicide headaches" due to their severity. The drug is administered as a monthly self-injection (or a one-time loading dose for cluster headaches), making it a convenient option for people who need long-term preventive therapy. If you're having trouble finding Emgality, FindUrMeds can locate it at a pharmacy near you.

How Does Emgality Work?

Emgality works by blocking calcitonin gene-related peptide, better known as CGRP. CGRP is a small protein released in the trigeminal nerve system — the nerve network around your head, face, and neck — and it plays a central role in triggering the cascade of events that leads to a migraine attack. During a migraine, CGRP levels spike dramatically, causing blood vessels to dilate, inflammation to spread, and pain signals to amplify. Emgality is a monoclonal antibody, meaning it's an engineered protein that binds directly to CGRP and neutralizes it before it can attach to its receptors and set off that chain reaction. Think of it like a catcher's mitt that intercepts the signal before it ever reaches the pain center. It doesn't just mask pain — it reduces how often attacks happen in the first place.

Because Emgality is a large-molecule biologic delivered by injection, it works differently from pills. After a subcutaneous injection (just under the skin, typically in the abdomen, thigh, or upper arm), the drug is gradually absorbed into the bloodstream, reaching peak concentration in approximately 5 days. Its half-life is around 27 days, which is why a single monthly injection maintains consistent therapeutic levels throughout the month. Most patients begin noticing a reduction in migraine days within the first month of treatment, though the full benefit often builds over 3 to 6 months of consistent use. Each prefilled pen or syringe contains a 120 mg dose (or 300 mg for the cluster headache loading dose), designed for easy at-home administration without a clinic visit.

Available Doses of Emgality

Emgality is available in the following FDA-approved strengths:

120 mg/mL prefilled pen — The standard monthly maintenance dose for migraine prevention. This is the most commonly prescribed form and the one most patients will use long-term.
120 mg/mL prefilled syringe — Same dose and concentration as the pen, offered as an alternative delivery device for patients who prefer a traditional syringe.
100 mg/mL prefilled syringe — Used in the 300 mg loading dose regimen for cluster headaches; patients receive three consecutive 100 mg injections at the start of a cluster period.

Most common starting dose: For migraine prevention, the standard starting dose is 240 mg (two 120 mg injections given consecutively) as a loading dose, followed by 120 mg once monthly. For episodic cluster headache, the starting regimen is 300 mg (three 100 mg injections) at the onset of the cluster period, then 300 mg monthly until the end of the cluster period.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Emgality Findability Score

Emgality Findability Score: 82 / 100

Our Findability Score is a proprietary metric that reflects how readily available a given medication is across our network of 15,000+ US pharmacy locations. A score of 1 means the drug is exceptionally difficult to locate — think DEA quota-restricted controlled substances, FDA-listed shortage drugs, or medications with severe supply chain disruptions. A score of 100 means you can walk into virtually any pharmacy and find it on the shelf. Emgality's score of 82 puts it in the "generally accessible" range, with some important caveats that patients should understand before they start calling around.

Several factors contribute to Emgality's relatively strong availability. Unlike controlled substances, galcanezumab is not subject to DEA manufacturing quotas — a major supply bottleneck that plagues drugs like Adderall and some opioids. It is not currently listed on the ASHP Drug Shortage Database, which is a positive sign. Eli Lilly has maintained stable domestic production since the drug's 2018 launch, and because Emgality competes in an active market alongside Aimovig and Ajovy, manufacturers have a strong commercial incentive to keep supply chains robust. Based on ASHP Drug Shortage Database records and our own platform data, CGRP-class injectables have not experienced the widespread shortages that have affected small-molecule neurological drugs in recent years.

That said, an 82 is not a 100. Practically speaking, this means Emgality is stocked by most major pharmacy chains — CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — but it is not always on the shelf at every individual location. Because it is a biologic injectable stored under refrigeration, smaller independent pharmacies may not carry it routinely and may require a special order. Stock levels can also vary by region; rural areas or lower-volume pharmacy locations may have gaps that take a few days to resolve. According to our data across 50,000+ pharmacy searches, patients looking for Emgality contact an average of 3–5 pharmacies before finding it in stock — significantly fewer than hard-to-find medications that average 7–12 calls.

Our platform's analysis of Emgality availability found a success rate of approximately 94% within 24–48 hours — slightly above our overall 92% platform average, reflecting the drug's strong but not universal availability. If you're hitting roadblocks, it almost certainly means a stock gap at specific locations, not a true national shortage. Skip the pharmacy calls. FindUrMeds finds Emgality for you.

Emgality Pricing

Emgality is a branded biologic with no generic equivalent, which puts it firmly in the higher price tier. Here's a realistic breakdown of what patients can expect to pay:

With Insurance: Most commercial insurance plans that cover Emgality place it on a specialty or Tier 3–5 formulary level. Copays typically range from $0 to $50 per month for patients with solid commercial coverage and an active Eli Lilly copay card. Medicare Part D enrollees may face significantly higher out-of-pocket costs, often in the range of $100–$500 per month depending on their plan's formulary and coverage phase. Prior authorization is almost universally required — expect your prescriber to need to document that you've tried and failed at least 2–3 standard preventive options before insurance approves Emgality.

Without Insurance (Cash Price): The list price for Emgality is approximately $900–$1,000 per month for the standard 120 mg dose. Without assistance programs, this is out of reach for most patients paying out of pocket.

GoodRx Estimated Price: GoodRx and similar discount platforms can bring the cash price down to approximately $700–$850 per month at participating pharmacies, depending on location and specific coupon applied. Prices vary meaningfully by chain and region, so checking multiple GoodRx coupons across different pharmacies in your area is worth doing.

Manufacturer Patient Assistance: Eli Lilly offers two important programs patients should know about:

Lilly Cares Foundation Patient Assistance Program: For uninsured or underinsured patients who meet income eligibility requirements, Emgality may be available at no cost or significantly reduced cost. Visit lillycares.com or ask your prescriber's office to help you apply.
Emgality Savings Card: Eligible commercially insured patients may pay as little as $5 per month through Lilly's copay card program. As of this writing, patients can activate the card at emgality.com. Note: This card is not valid for patients with Medicare, Medicaid, or other federal or state government insurance programs.

Price varies by pharmacy, region, and insurance plan. Always confirm your actual cost with your specific pharmacy and insurance before filling.

Who Can Prescribe Emgality?

Emgality is a prescription medication, but because it is not a controlled substance, it does not carry the special prescribing restrictions that apply to, say, stimulants or opioids. The following healthcare providers can legally prescribe Emgality in most US states:

Neurologists — The most common prescribers. Headache specialists and general neurologists are deeply familiar with the CGRP class and typically lead preventive migraine management.
Headache Specialists — A subset of neurologists with additional focus on migraine and cluster headache; often the go-to for complex or treatment-refractory cases.
Primary Care Physicians (MDs and DOs) — Fully authorized to prescribe Emgality, and increasingly doing so for patients with well-established migraine diagnoses who don't require specialist evaluation.
Nurse Practitioners (NPs) — Licensed to prescribe in all 50 states (with varying supervision requirements); many NPs in neurology or primary care practices routinely prescribe CGRP medications.
Physician Assistants (PAs) — Similarly authorized to prescribe in all states, under collaborating physician agreements where required by state law.
Psychiatrists — Less commonly, but may prescribe when migraine is comorbid with mental health conditions being managed concurrently.
OB/GYNs and Women's Health Specialists — Sometimes involved in prescribing for patients whose migraines are hormonally driven.

Telemedicine: Emgality can be prescribed via telehealth. Because it is non-controlled, there are no federal restrictions on telemedicine prescribing comparable to those that apply to stimulants or benzodiazepines post-COVID. Platforms like Teladoc, MDLive, and specialty neurology telehealth services can evaluate and prescribe Emgality in most states after an appropriate clinical consultation. Your initial telehealth visit will still likely require documented migraine history and prior treatment records.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Emgality Side Effects

Emgality has a notably clean side effect profile compared to older migraine preventives like valproate, topiramate, or amitriptyline — many of which cause cognitive side effects, weight changes, or mood disruption. That said, no medication is completely without side effects.

Most Common Side Effects

These are the reactions reported most frequently in clinical trials and real-world use:

Injection site reactions — Redness, pain, itching, or bruising at the site of injection. Reported by approximately 18% of patients in clinical trials. Usually mild and resolves within hours to a day.
Injection site nodule — A small, firm bump under the skin that can form after the injection. Generally harmless and typically resolves on its own within days to weeks.
Constipation — A GI side effect noted across the CGRP class. CGRP also plays a role in gut motility, so blocking it systemically can slow things down for some patients.
Erythema (skin redness) — Localized redness that may extend slightly beyond the injection site; distinct from a systemic allergic reaction in most cases.

Less Common but Serious Side Effects

These are rarer but warrant prompt attention:

Hypersensitivity or allergic reactions — Including rash, urticaria (hives), and in rare cases, anaphylaxis. Contact your provider immediately or call 911 if you experience difficulty breathing, swelling of the throat or face, or sudden severe skin reactions after injection.
Serious skin reactions — Cases of severe hypersensitivity with delayed onset (days after injection) have been reported. Contact your provider if you develop a spreading rash or significant skin involvement.
Cardiovascular considerations — CGRP is a vasodilator, and blocking it long-term raised theoretical concerns about cardiovascular effects, particularly in patients with ischemic heart disease. Clinical trial data have been reassuring, but if you have a history of heart attack, stroke, or significant cardiovascular disease, discuss this specifically with your cardiologist and neurologist before starting.

Side Effects That Typically Improve Over Time

Injection site discomfort is the side effect most patients report as their primary complaint — and it is also the one most likely to diminish with continued use. Letting the prefilled pen sit at room temperature for 30 minutes before injecting can significantly reduce injection pain. Rotating injection sites also helps reduce cumulative skin irritation. Most patients who continue past the first 2–3 injections find the process becomes routine and well-tolerated.

This section is for informational purposes only. Talk to your doctor or pharmacist about any side effects you experience. Do not discontinue Emgality without consulting your prescriber.

Alternatives to Emgality

If Emgality isn't working, isn't available, or isn't covered by your insurance, there are meaningful alternatives — both within the same drug class and from entirely different mechanisms.

Same-Class Alternatives

These are the other FDA-approved CGRP monoclonal antibodies for migraine prevention. They work by the same general mechanism as Emgality but differ in molecular target, dosing schedule, and available formulations:

Aimovig (erenumab, Amgen/Novartis) — The first CGRP antibody approved (May 2018). Available in 70 mg and 140 mg monthly self-injections. Targets the CGRP receptor rather than the ligand itself — a meaningful pharmacological distinction that means patients who don't respond to Emgality may still respond to Aimovig, and vice versa.
Ajovy (fremanezumab, Teva) — Available in 225 mg monthly or 675 mg quarterly doses. The quarterly option is a major convenience factor for patients who prefer less frequent injections. Targets the CGRP ligand, similar to Emgality.
Vyepti (eptinezumab, Lundbeck) — An IV infusion administered every 3 months in a clinical setting. Same CGRP ligand target, but delivered intravenously rather than by self-injection, which some patients find more reassuring for adherence.

Different-Mechanism Alternatives

For patients who need a completely different approach — due to insurance restrictions, intolerance, or clinical preference:

Qulipta (atogepant, AbbVie) — An oral CGRP receptor antagonist (gepant class). Daily pill instead of injection. FDA-approved specifically for preventive treatment of episodic, chronic, and high-frequency episodic migraine.
Nurtec ODT (rimegepant, Pfizer/BioHaven) — Another oral gepant, FDA-approved for both acute migraine treatment and preventive use (every other day dosing). Offers flexibility to treat attacks and prevent them with one drug.
Topamax/topiramate (generic available) — An anticonvulsant with decades of use in migraine prevention. Much cheaper with generics available, but associated with cognitive side effects ("Dopamax") that many patients find limiting.
Propranolol/metoprolol — Beta-blockers with FDA approval for migraine prevention. Widely available and inexpensive. Not suitable for patients with asthma, certain heart conditions, or those prone to fatigue.
Amitriptyline/nortriptyline — Tricyclic antidepressants used off-label for migraine prevention. Effective and cheap, but sedation, weight gain, and dry mouth are common complaints.
Botox (onabotulinumtoxinA) — FDA-approved for chronic migraine (15+ headache days per month). Administered as 31 injections across the head and neck every 12 weeks in a clinical setting. Very effective for high-frequency sufferers.

If you'd prefer to stick with Emgality, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Emgality

One of the practical advantages of Emgality is its relatively limited drug interaction profile. Because it is a large-molecule biologic that doesn't go through cytochrome P450 liver enzymes (the metabolic pathway responsible for most classic drug-drug interactions), it avoids many of the interaction concerns common to small-molecule drugs. That said, interactions do exist and should be discussed with your prescriber.

Serious Interactions

Other CGRP-targeting agents — Combining Emgality with other CGRP pathway drugs (e.g., Aimovig, Ajovy, Vyepti, or the gepant class including Nurtec and Qulipta) is generally not recommended. The safety and efficacy of combination CGRP blockade have not been established in controlled trials, and the theoretical risk of compounding cardiovascular effects (CGRP's vasodilatory role) warrants caution. Your neurologist may make individualized decisions, but this combination requires explicit clinical justification.
Triptans in patients with cardiovascular disease — Not a direct Emgality interaction, but patients with known cardiovascular risk who are also using triptans (sumatriptan, rizatriptan, etc.) for acute migraine alongside Emgality should discuss the combined vasoconstrictive and vasodilatory implications with their cardiologist.

Moderate Interactions

Ergotamine derivatives — Ergotamine and dihydroergotamine (DHE) are vasoconstrictors used for acute migraine and cluster headache. While not a pharmacokinetic interaction, co-use with CGRP-blocking agents that affect vascular tone deserves monitoring. Report any unusual chest discomfort, limb coldness, or blood pressure changes to your provider.
Immunosuppressants — Emgality is an antibody and could theoretically interact with medications that alter immune function. In practice, clinical data are limited, and your prescriber should be aware of all immunomodulating drugs you take.

Food and Substance Interactions

Caffeine — No direct pharmacokinetic interaction with galcanezumab, but caffeine overuse (more than 10 cups of coffee per week or regular use of caffeine-containing headache medications) can contribute to medication-overuse headache and undermine Emgality's preventive effect. Your neurologist may ask you to reduce caffeine as part of an overall migraine management plan.
Alcohol — Similarly, no direct interaction with the drug's mechanism, but alcohol is a well-documented migraine trigger for many patients. Heavy or frequent alcohol use may blunt the clinical benefit you'd otherwise get from Emgality.
Grapefruit — No known interaction. Grapefruit-related CYP3A4 interactions don't apply to biologics like Emgality.
Cannabis — Limited formal data. Some patients report cannabis helps acute migraine; others find it triggers attacks. No established pharmacokinetic interaction, but discuss with your provider if you use cannabis regularly.

Always tell every member of your healthcare team about all prescription drugs, over-the-counter medications, supplements, and substances you use.

How to Find Emgality in Stock

This is where most patients hit a wall. You have the prescription — you just can't find a pharmacy that has it. Emgality is a refrigerated biologic stocked in lower quantities than mass-market pills, which means individual pharmacy locations run out, and calling around manually is frustrating and time-consuming. Here's a practical, step-by-step approach.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built specifically for this problem. Here's how it works:

You submit your prescription information online — Tell us the medication name (Emgality), dose, and your zip code. No account required to get started.
We contact pharmacies across 15,000+ locations on your behalf — Our team calls CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, Sam's Club, and independent pharmacies in your area, checking real-time stock for your specific dose and quantity.
You get a confirmed result within 24–48 hours — We tell you exactly which pharmacy has it in stock, so you can send your prescription directly there and pick it up without any runaround. Our success rate for Emgality is approximately 94%.

Patients using FindUrMeds report an average of zero wasted pharmacy trips — because we do the calling before you go anywhere.

2. Check GoodRx — The Price-Listing Stock Hack

Here's a trick many patients don't know: GoodRx only displays coupons for pharmacies that have a given medication in their dispensing system. If a pharmacy location isn't showing a GoodRx price for Emgality, it often signals the drug isn't stocked there. Conversely, if multiple locations are showing GoodRx prices in your zip code, that's a useful proxy signal for where inventory is likely available. Go to goodrx.com, search "galcanezumab," and look at the pharmacy-by-pharmacy price breakdown. Call the top 2–3 locations showing prices to confirm actual on-hand stock.

3. Check Pharmacy Apps and Websites

Major chains have improved their digital tools significantly, and some allow you to check or request specific medication availability:

CVS app/website — Use the "Check Drug Price" tool with your zip code. If a store location returns a price, the medication is likely in their formulary for that store. Call to confirm physical stock.
Walgreens app — Walgreens has a prescription transfer and stock inquiry feature. You can also use their chat function to ask about Emgality availability at specific branches before calling.
Walmart Pharmacy — Walmart's pharmacy locator lets you search by medication. For specialty biologics like Emgality, the Walmart Health & Wellness app can connect you with pharmacy staff quickly to check inventory.
Costco and Sam's Club — Both offer competitive pricing on Emgality for members. Costco's pharmacy has a reputation for strong biologic inventory due to their bulk purchasing model. Call the pharmacy directly using the warehouse locator on costco.com — they're often more responsive by phone than their app suggests.

4. Call with the Generic Name

Pharmacy technicians will look up stock faster and more accurately if you use the scientific name, not just the brand name. Here's a script that works:

"Hi, I'm looking for galcanezumab — that's the generic name for Emgality. Do you have it in stock in any strength? I'm specifically looking for the 120 mg prefilled pen, but I'd also like to know about the syringe form."

Using the generic name signals that you know what you're looking for, reduces the chance of a miscommunication, and lets the technician search the inventory system more precisely. If they don't have it, always ask: "Do you know when you might have it, or could you check if a nearby location of yours has it in stock?" Many chains can see inventory at other branches.

Ready to stop calling pharmacies?

FindUrMeds locates Emgality for you — usually within 24–48 hours. We search 15,000+ pharmacies nationwide, including CVS, Walgreens, Walmart, Costco, and more. 94% success rate for Emgality. Trusted by 200+ healthcare providers.

Find Emgality Near You →

Frequently Asked Questions

Is Emgality still in shortage?

As of this writing, Emgality (galcanezumab) is not listed on the FDA Drug Shortage Database or the ASHP Drug Shortage Database. Eli Lilly has maintained consistent domestic manufacturing and distribution since the drug's approval in 2018. Localized stock gaps at individual pharmacy locations do occur — particularly at smaller or lower-volume pharmacies — but these are inventory management issues, not a national shortage. Based on our platform's analysis of Emgality availability, most patients can locate their dose within 24–48 hours using a systematic search. If you're hearing "we don't have it" from multiple pharmacies, try larger chains like Costco or Walgreens specialty pharmacy, or use FindUrMeds to search more broadly.

How much does Emgality cost without insurance?

Without insurance or a discount program, Emgality's list price runs approximately $900–$1,000 per month for the standard 120 mg monthly dose. With a GoodRx coupon, prices can drop to approximately $700–$850 at participating pharmacies. If you're uninsured, the most important step is applying to Eli Lilly's patient assistance programs: the Lilly Cares Foundation may provide Emgality at no cost for eligible patients based on income, and the Emgality Savings Card can bring costs down to $5/month for commercially insured patients. Call 1-800-545-5979 or visit lillycares.com to start an application. Always confirm current pricing at your specific pharmacy, as costs can vary by location.

Can I get Emgality through mail order?

Yes — and for a monthly injectable like Emgality, mail order or specialty pharmacy is often the most reliable option. Most major insurance plans with mail order pharmacy benefits (CVS Caremark, Express Scripts, OptumRx) can deliver Emgality in temperature-controlled packaging directly to your home. Specialty pharmacies like Walgreens Specialty, CVS Specialty, and Accredo are specifically set up to handle refrigerated biologics and often have more consistent inventory than retail locations. Ask your prescriber to send the prescription to a specialty pharmacy if you're having repeated trouble at retail locations. Mail order typically requires 7–10 business days for the first fill, so plan ahead before your next dose is due.

What's the difference between Emgality and Aimovig?

Both Emgality and Aimovig are CGRP monoclonal antibodies approved for migraine prevention, but they differ in one important pharmacological way: Aimovig targets the CGRP receptor, while Emgality (and Ajovy and Vyepti) target the CGRP molecule itself. In practical terms, this means the two drugs block the same pain pathway at different points — which is why some patients who don't respond to one may still respond to the other. Dosing also differs: Aimovig comes in 70 mg or 140 mg monthly injections, while Emgality starts with a 240 mg loading dose followed by 120 mg monthly. Both have comparable efficacy data (reducing monthly migraine days by approximately 4–5 days in clinical trials), similar safety profiles, and require prior authorization from most insurers. The choice between them often comes down to insurance formulary placement, prescriber familiarity, and individual patient response. Only your neurologist can determine which is the better fit for your clinical situation.

What if my pharmacy is out of Emgality?

Don't give up — a "we're out" at one pharmacy doesn't mean Emgality isn't available nearby. Here's what to do:

Ask about restocking timelines. Most pharmacies can tell you when their next biologic delivery is scheduled — often within 2–3 business days.
Ask them to check other branch locations. Chain pharmacies can often see inventory at nearby stores and transfer your prescription.
Try a specialty pharmacy. Walgreens Specialty, CVS Specialty, and Accredo maintain more reliable biologic inventory than general retail.
Check GoodRx for price listings at other pharmacies in your area as a stock proxy.
Use FindUrMeds. We call across our network of 15,000+ pharmacies and identify confirmed stock — usually within 24–48 hours. Patients using our service for Emgality avoid an average of 3–5 wasted calls.

If you're due for a dose and stock is delayed, contact your prescriber — in some cases they can provide a sample, adjust your refill timing, or contact specialty pharmacies directly on your behalf.

Need help finding Emgality in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Emgality Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Emgality

Findability Score: 40/100